News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,125 Results
Type
Article (15886)
Company Profile (17)
Press Release (164222)
Section
Business (49160)
Career Advice (319)
Deals (7554)
Drug Delivery (25)
Drug Development (24397)
Employer Resources (29)
FDA (3817)
Job Trends (4061)
News (84283)
Policy (6697)
Tag
Academia (1750)
Alliances (15372)
Alzheimer's disease (499)
Approvals (3809)
Artificial intelligence (43)
Bankruptcy (82)
Best Places to Work (3440)
Breast cancer (38)
Cancer (433)
Cardiovascular disease (26)
Career advice (285)
CAR-T (24)
Cell therapy (85)
Clinical research (18992)
Collaboration (144)
COVID-19 (1080)
C-suite (30)
Data (342)
Diabetes (24)
Diagnostics (1855)
Drug pricing (28)
Earnings (12610)
Employer resources (24)
Events (22799)
Executive appointments (87)
FDA (3974)
Funding (149)
Gene therapy (59)
GLP-1 (138)
Government (1335)
Healthcare (5793)
Infectious disease (1106)
Inflammatory bowel disease (30)
Interviews (32)
IPO (3622)
Job creations (718)
Job search strategy (264)
Layoffs (82)
Legal (1185)
Lung cancer (64)
Manufacturing (49)
Medical device (3202)
Medtech (3204)
Mergers & acquisitions (3983)
Metabolic disorders (69)
Neuroscience (566)
NextGen Class of 2024 (1911)
Non-profit (2026)
Northern California (391)
Obesity (36)
Opinion (59)
People (17316)
Phase I (6950)
Phase II (8393)
Phase III (5536)
Pipeline (147)
Policy (41)
Postmarket research (681)
Preclinical (2588)
Radiopharmaceuticals (94)
Rare diseases (56)
Real estate (1435)
Regulatory (4527)
Research institute (1890)
Resumes & cover letters (39)
Southern California (319)
Startups (1214)
United States (3568)
Vaccines (186)
Date
Today (28)
Last 7 days (214)
Last 30 days (986)
Last 365 days (9920)
2024 (9014)
2023 (11433)
2022 (15095)
2021 (16033)
2020 (15302)
2019 (13879)
2018 (10272)
2017 (9251)
2016 (9106)
2015 (10683)
2014 (7833)
2013 (6469)
2012 (6640)
2011 (6945)
2010 (5986)
Location
Africa (205)
Alabama (23)
Arizona (48)
Asia (11074)
Australia (2558)
California (817)
Canada (288)
China (64)
Colorado (45)
Connecticut (39)
Europe (24477)
Florida (156)
Illinois (106)
Indiana (73)
Japan (24)
Kansas (27)
Maryland (155)
Massachusetts (594)
Michigan (24)
Minnesota (57)
New Jersey (331)
New York (260)
North Carolina (158)
Northern California (391)
Ohio (45)
Pennsylvania (193)
South America (292)
Southern California (319)
Texas (159)
Washington D.C. (23)
Washington State (123)
180,125 Results for "max planck institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Immunome Announces Promotion of Max Rosett to Chief Financial Officer
Immunome, Inc. today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9.
May 17, 2024
·
5 min read
Business
Orthofix Names Max Reinhardt President of Global Spine Business
Orthofix Medical Inc today announced the appointment of Max Reinhardt as President of the Global Spine business effective June 10, 2024.
May 23, 2024
·
4 min read
Business
HuidaGene and Synthego Announce Licensing Agreement on Next-Generation Gene Editing Enzyme, hfCas12Max
HuidaGene Therapeutics and Synthego Corporation (“Synthego”), a leading provider of innovative CRISPR solutions for developing cell and gene therapies, proudly announce a partnered licensing agreement for the high-fidelity Cas12 CRISPR nuclease (hfCas12Max).
May 29, 2024
·
3 min read
Press Releases
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
October 16, 2024
·
4 min read
Press Releases
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
October 8, 2024
·
3 min read
Press Releases
Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
September 18, 2024
·
3 min read
BiondVax’s Strategic Research Collaboration with Max Planck and UMG: Significant progress towards development of innovative nanosized antibodies (NanoAbs) for therapeutic indications in addition to COVID-19
BiondVax Pharmaceuticals Ltd. provided encouraging updates related to the strategic research collaboration between BiondVax, the Max Planck Institute for Multidisciplinary Sciences, and the University Medical Center Göttingen towards the development of a pipeline of innovative alpaca–derived nanosized antibody therapies.
September 20, 2022
·
6 min read
Business
MAX BioPharma and Metaba Announce Collaboration on Metabolomics Studies
MAX BioPharma, Inc. and Metaba, LLC announced their collaboration in studying the effects of oxysterol drug candidates that target non-alcoholic steatohepatitis, idiopathic pulmonary fibrosis, chronic inflammation, and atherosclerosis on metabolic processes using Metaba’s state of the art metabolomics platform technology.
February 26, 2024
·
4 min read
Press Releases
MAX BioPharma announces key update on its anti-fibrotic and anti-inflammatory oxysterol drug candidate that inhibits MASH, atherosclerosis, and fat tissue inflammation
October 25, 2024
·
5 min read
Press Releases
Venus Concept Announces Regulatory Approval for Venus Bliss MAX in Canada
July 29, 2024
·
3 min read
1 of 18,013
Next
